JAZZ logo

Jazz Pharmaceuticals (JAZZ)

Profile

Full Name

Jazz Pharmaceuticals plc

Ticker Symbol

JAZZ

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

Ireland

IPO

June 1, 2007

Indexes

Not included

Website

http://www.jazzpharma.com

Employees

2800

Key Details

Price

$109.44(+3.13%)

Market cap

$6.75B(Mid cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$4.07B(+6.12% YoY)

Annual EPS

$8.65(+41.80% YoY)

PE ratio

14.59

Next earnings date

Jul 31, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $109.44
    JAZZ price is $109.44

    30-Day Relative Volume

    0.96
    JAZZ 30-day relative volume is 0.96

    Price Performance

    Price Most recent change

    +3.13%
    JAZZ price was up +3.13% on Jul 1, 2025

    Price YTD change

    -11.13%
    JAZZ price is down -11.13% since January 1st

    Price 1-year change

    +2.79%
    JAZZ price is up +2.79% year-on-year

    Price 3-year change

    -30.99%
    JAZZ price is down -30.99% over the past 3 years

    Price Range

    Price All-time high

    $194.73
    JAZZ price is currently -43.80% below its historical high of $194.73

    Price 3-year low

    $95.49
    JAZZ price is currently +14.61% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $6.75B
    JAZZ market capitalization is $6.75 billion

    Market cap 3-year change

    -32.08%
    JAZZ market capitalization is down -32.08% over the past 3 years

    Market cap All-time high

    $11.82B
    JAZZ market capitalization is currently -42.96% below its historical high of $11.82 billion

    Market cap sector rank

    90.34%
    JAZZ market capitalization is higher than 90.34% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    -0.18%
    JAZZ shares outstanding is down -0.18% year-on-year

    Shares Outstanding 3-Year Change

    -1.58%
    JAZZ shares outstanding is down -1.58% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.80
    JAZZ beta is 0.80

    200-day SMA

    $118.21
    JAZZ price is currently -7.42% below its 200-day simple moving average

    50-day SMA

    $108.61
    JAZZ price is currently +0.76% above its 50-day simple moving average

    RSI

    52.31
    JAZZ 14-day relative strength index is 52.31

    Volume

    0.96
    JAZZ 30-day relative volume is 0.96

    ATR

    $3.04
    JAZZ average true range is $3.04

    10-day Historical Volatility

    24.22%
    JAZZ 10-day historical volatility is 24.22%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $4.07B
    JAZZ annual revenue is $4.07 billion

    Revenue Analysts estimate

    $4.23B
    JAZZ annual revenue is currently -3.71% lower than the consensus analysts' forecast

    Revenue 1-year change

    +6.12%
    JAZZ annual revenue is up +6.12% year-on-year

    Revenue Sector rank

    90.95%
    JAZZ annual revenue is higher than 90.95% of companies in Healthcare sector

    EPS

    EPS

    $8.65
    JAZZ annual earnings per share is $8.65

    EPS Analysts estimate

    $5.01
    JAZZ annual earnings per share is currently +72.72% higher than the consensus analysts' forecast

    EPS 1-year change

    +41.8%
    JAZZ annual earnings per share is up +41.8% year-on-year

    EPS Sector rank

    97.61%
    JAZZ annual earnings per share is higher than 97.61% of companies in Healthcare sector

    Profit

    Gross profit

    $3.62B
    JAZZ annual gross profit is $3.62 billion

    Gross margin

    89.05%
    JAZZ annual gross profit margin is 89.05%

    Operating profit

    $726.63M
    JAZZ annual operating income is $726.63 million

    Operating margin

    17.86%
    JAZZ annual operating profit margin is 17.86%

    Net income

    $560.12M
    JAZZ annual net profit is $560.12 million

    Net margin

    13.77%
    JAZZ annual net profit margin is 13.77%

    Expenses

    Total expenses

    $3.34B
    JAZZ annual total expenses is $3.34 billion

    Operating expenses

    $2.90B
    JAZZ annual total operating expenses is $2.90 billion

    Cost of goods sold

    $445.71M
    JAZZ annual cost of goods sold is $445.71 million

    Selling, general & administrative expenses

    $1.39B
    JAZZ annual SGA is $1.39 billion

    Depreciation and amortization

    $660.07M
    JAZZ annual depreciation & amortization is $660.07 million

    Interest expense

    $238.10M
    JAZZ annual interest expense is $238.10 million

    Income tax

    -$91.43M
    JAZZ annual income tax is -$91.43 million

    EBIT & EBITDA

    EBIT

    $708.45M
    JAZZ annual earnings before interest & taxes is $708.45 million

    EBITDA

    $1.37B
    JAZZ annual EBITDA is $1.37 billion

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $12.01B
    JAZZ annual total assets is $12.01 billion

    Non current assets

    $7.38B
    JAZZ annual long term assets is $7.38 billion

    Current assets

    $4.63B
    JAZZ annual total current assets is $4.63 billion

    Cash and cash equivalents

    $2.41B
    JAZZ annual cash & cash equivalents is $2.41 billion

    Accounts receivable

    $716.76M
    JAZZ annual accounts receivable is $716.76 million

    Inventory

    $480.44M
    JAZZ annual inventory is $480.44 million

    Liabilities

    Total liabilities

    $7.92B
    JAZZ annual total liabilities is $7.92 billion

    Long term liabilities

    $6.88B
    JAZZ annual total long term liabilities is $6.88 billion

    Current liabilities

    $1.04B
    JAZZ annual total current liabilities is $1.04 billion

    Accounts payable

    $77.87M
    JAZZ annual accounts payable is $77.87 million

    Debt

    Total debt

    $6.16B
    JAZZ annual total debt is $6.16 billion

    Total debt 1-year change

    +6.4%
    JAZZ annual total debt is up +6.4% year-on-year

    Long term debt

    $6.12B
    JAZZ annual long term debt is $6.12 billion

    Short term debt

    $45.78M
    JAZZ annual short term debt is $45.78 million

    Equity & Capital

    Shareholders equity

    $4.09B
    JAZZ annual stockholders equity is $4.09 billion

    Book value

    $4.09B
    JAZZ annual book value is $4.09 billion

    Retained earnings

    $1.13B
    JAZZ annual retained earnings is $1.13 billion

    Working capital

    $3.59B
    JAZZ annual working capital is $3.59 billion

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $1.40B
    JAZZ annual cash flow from operations is $1.40 billion

    Cash from operations 1-year change

    +27.83%
    JAZZ annual cash flow from operations is up +27.83% year-on-year

    Cash from investing

    -$508.19M
    JAZZ annual cash flow from investing activities is -$508.19 million

    Cash from investing 1-year change

    -211.66%
    JAZZ annual cash flow from investing activities is down -211.66% year-on-year

    Cash from financing

    $20.52M
    JAZZ annual cash flow from financing activities is $20.52 million

    Cash from financing 1-year change

    +106.72%
    JAZZ annual cash flow from financing activities is up +106.72% year-on-year

    CAPEX

    CAPEX

    $48.07M
    JAZZ annual capital expenditures is $48.07 million

    CAPEX 1-year change

    +11.89%
    JAZZ annual capital expenditures is up +11.89% year-on-year

    Free Cash Flow

    Free cash flow

    $1.35B
    JAZZ annual free cash flow is $1.35 billion

    Free cash flow 1-year change

    +28.48%
    JAZZ annual free cash flow is up +28.48% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    89.05%
    JAZZ annual gross profit margin is 89.05%

    Operating margin

    17.86%
    JAZZ annual operating profit margin is 17.86%

    Net margin

    13.77%
    JAZZ annual net profit margin is 13.77%

    ROA & ROE

    ROA

    4.79%
    JAZZ annual return on assets is 4.79%

    ROE

    14.31%
    JAZZ annual return on equity is 14.31%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    14.59
    JAZZ price to earnings ratio is 14.59

    PE ratio Sector rank

    27.1%
    JAZZ price to earnings ratio is higher than 27.1% of companies in Healthcare sector

    PB Ratio

    PB ratio

    1.62
    JAZZ price to book ratio is 1.62

    PB ratio Sector rank

    51.76%
    JAZZ price to book ratio is higher than 51.76% of companies in Healthcare sector

    PS Ratio

    PS ratio

    1.66
    JAZZ price to sales ratio is 1.66

    PS ratio Sector rank

    36.03%
    JAZZ price to sales ratio is higher than 36.03% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $10.30B
    JAZZ enterprise value is $10.30 billion

    Enterprise value Sector rank

    91.59%
    JAZZ enterprise value is higher than 91.59% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    8.32
    JAZZ EV/EBITDA is 8.32

    EV/EBITDA Sector rank

    80.68%
    JAZZ EV/EBITDA is higher than 80.68% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    4.46
    JAZZ annual current ratio is 4.46

    Quick ratio

    3.99
    JAZZ annual quick ratio is 3.99

    Leverage

    Debt to equity

    1.49
    JAZZ annual debt to equity ratio is 1.49

    Interest coverage ratio

    2.98
    JAZZ annual interest coverage ratio is 2.98

    Risk & Stability

    Piotroski F-Score

    6
    JAZZ piotroski f-score is 6

    Altman Z-Score

    1.53
    JAZZ altman z-score is 1.53

    Analyst ratings

    Recent major analysts updates

    May 7, 25 RBC Capital
    Outperform
    May 7, 25 Piper Sandler
    Overweight
    May 7, 25 Needham
    Buy
    May 7, 25 Morgan Stanley
    Overweight
    May 7, 25 Baird
    Outperform
    Apr 10, 25 Needham
    Buy
    Mar 10, 25 HC Wainwright & Co.
    Buy
    Mar 7, 25 UBS
    Buy
    Mar 6, 25 Truist Securities
    Buy
    Mar 5, 25 Needham
    Buy

    Institutional Ownership

    Screeners with JAZZ included

    Mid cap stocks
    High Piotroski score stocks
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    Companies with buyback
    • What is the ticker symbol for Jazz Pharmaceuticals?
    • Does Jazz Pharmaceuticals pay dividends?
    • What sector is Jazz Pharmaceuticals in?
    • What industry is Jazz Pharmaceuticals in?
    • What country is Jazz Pharmaceuticals based in?
    • When did Jazz Pharmaceuticals go public?
    • Is Jazz Pharmaceuticals in the S&P 500?
    • Is Jazz Pharmaceuticals in the NASDAQ 100?
    • Is Jazz Pharmaceuticals in the Dow Jones?
    • When was Jazz Pharmaceuticals's last earnings report?
    • When does Jazz Pharmaceuticals report earnings?
    • Should I buy Jazz Pharmaceuticals stock now?

    What is the ticker symbol for Jazz Pharmaceuticals?

    The ticker symbol for Jazz Pharmaceuticals is NASDAQ:JAZZ

    Does Jazz Pharmaceuticals pay dividends?

    No, Jazz Pharmaceuticals does not pay dividends

    What sector is Jazz Pharmaceuticals in?

    Jazz Pharmaceuticals is in the Healthcare sector

    What industry is Jazz Pharmaceuticals in?

    Jazz Pharmaceuticals is in the Biotechnology industry

    What country is Jazz Pharmaceuticals based in?

    Jazz Pharmaceuticals is headquartered in Ireland

    When did Jazz Pharmaceuticals go public?

    Jazz Pharmaceuticals's initial public offering (IPO) was on June 1, 2007

    Is Jazz Pharmaceuticals in the S&P 500?

    No, Jazz Pharmaceuticals is not included in the S&P 500 index

    Is Jazz Pharmaceuticals in the NASDAQ 100?

    No, Jazz Pharmaceuticals is not included in the NASDAQ 100 index

    Is Jazz Pharmaceuticals in the Dow Jones?

    No, Jazz Pharmaceuticals is not included in the Dow Jones index

    When was Jazz Pharmaceuticals's last earnings report?

    Jazz Pharmaceuticals's most recent earnings report was on May 6, 2025

    When does Jazz Pharmaceuticals report earnings?

    The next expected earnings date for Jazz Pharmaceuticals is Jul 31, 2025

    Should I buy Jazz Pharmaceuticals stock now?

    As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
    On this page